Skip to main content

Peer Review reports

From: Seminal Papers in Urology: Darolutamide and survival in metastatic, hormone-sensitive prostate cancer

Original Submission
1 Mar 2023 Submitted Original manuscript
26 Jul 2023 Reviewed Reviewer Report - Matthew R. Sydes
26 Apr 2024 Author responded Author comments - Michael O'Callaghan
Resubmission - Version 2
26 Apr 2024 Submitted Manuscript version 2
4 Jun 2024 Author responded Author comments - Michael O'Callaghan
Resubmission - Version 3
4 Jun 2024 Submitted Manuscript version 3
Publishing
4 Jun 2024 Editorially accepted
1 Jul 2024 Article published 10.1186/s12894-024-01507-7

You can find further information about peer review here.

Back to article page